S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Jason Z. Liu,Federica Tozzi,Dawn M. Waterworth,Sreekumar G. Pillai,Pierandrea Muglia,Lefkos T. Middleton,Wade H. Berrettini,Christopher W. Knouff,Xin Yuan,Gérard Waeber,Peter Vollenweider,Martin Preisig,Nicholas J. Wareham,Jing Hua Zhao,Ruth J. F. Loos,Ins Barroso,Kay-Tee Khaw,Scott M. Grundy,Philip J. Barter,Robert W. Mahley,Antero Kesäniemi,Ruth McPherson,John B. Vincent,John Strauss,James L. Kennedy,Anne Farmer,Peter McGuffin,Richard O. Day,Keith Matthews,Per Bakke,Amund Gulsvik,Susanne Lucae,Marcus Ising,T. Brueckl,S. Horstmann,H.-Erich Wichmann,Rajesh Rawal,Norbert Dahmen,Claudia Lamina,Ozren Polasek,Lina Zgaga,Jennifer E. Huffman,Susan Campbell,Jaspal S. Kooner,John C. Chambers,Mary Susan Burnett,Joseph M. Devaney,Augusto D. Pichard,Kenneth M. Kent,Lowell F. Satler,Joseph M. Lindsay,Ron Waksman,Stephen E. Epstein,James F. Wilson,Sarah H. Wild,Harry Campbell,Veronique Vitart,Muredach P. Reilly,Mingyao Li,Liming Qu,Robert L. Wilensky,William H. Matthai,Hakon Hakonarson,Daniel J. Rader,Andre Franke,Michael Wittig,Arne Schäfer,Manuela Uda,Antonio Terracciano,Xiangjun Xiao,Fabio Busonero,Paul Scheet,David Schlessinger,David St Clair,Dan Rujescu,Gonçalo R. Abecasis,Hans J. Grabe,Alexander Teumer,Henry Völzke,Astrid Petersmann,Ulrich John,Igor Rudan,Igor Rudan,Caroline Hayward,Alan F. Wright,Ivana Kolcic,Benjamin J. Wright,John R. Thompson,Anthony J. Balmforth,Alistair S. Hall,Nilesh J. Samani,Carl A. Anderson,Tariq Ahmad,Christopher G. Mathew,Miles Parkes,Jack Satsangi,Mark J. Caulfield,Patricia B. Munroe,Martin Farrall,Anna F. Dominiczak,Jane Worthington,Wendy Thomson,Steve Eyre,Anne Barton,Vincent Mooser,Clyde Francks,Clyde Francks,Jonathan Marchini +107 more
TL;DR: The Oxford-GlaxoSmithKline study (Ox-GSK) as discussed by the authors performed a genome-wide meta-analysis of SNP association with smoking-related behavioral traits and found an effect on smoking quantity at a locus on 15q25 (P = 9.45 x 10(-19) that includes CHRNA5, CHRNA3 and CHRNB4.
Journal ArticleDOI
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Scott M. Grundy,Gloria Lena Vega,Mark E. McGovern,Brian R. Tulloch,David M. Kendall,David Fitz-Patrick,Om P. Ganda,Robert S. Rosenson,John B. Buse,David D. Robertson,John P. Sheehan +10 more
TL;DR: Low doses of ER niacin (1000 or 1500 mg/d) are a treatment option for dyslipidemia in patients with type 2 diabetes and no hepatotoxic effects or myopathy were observed.
Journal ArticleDOI
Improving Coronary Heart Disease Risk Assessment in Asymptomatic People Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests
TL;DR: Key findings and recommendations of the AHA Prevention V conference are amplified, new research since the conference is highlighted, and an approach to the use of office-based testing and additional noninvasive procedures in selected patients to better define their coronary event risk is proposed.
Journal ArticleDOI
Pre-diabetes, metabolic syndrome, and cardiovascular risk.
TL;DR: Pre-diabetes represents an elevation of plasma glucose above the normal range but below that of clinical diabetes, which can be identified as either impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), which is detected by oral glucose tolerance testing.
Journal ArticleDOI
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute
John C. LaRosa,D Hunninghake,D Bush,Michael H. Criqui,Godfrey S. Getz,Antonio M. Gotto,Scott M. Grundy,L Rakita,Rose Marie Robertson,M L Weisfeldt +9 more